GMI Co-Founder, Maurice Treacy, will be speaking this Thursday on the Precision Planet Panel at 11.30am PDT for the Precision Medicine Leadership Summit in San Diego, California. The geographically and experientially diverse group of leaders will explore the various challenges that governments, industry, and the nonprofit sector face when implementing the evolving technologies of precision medicine.
GMI Bioinformatician, Raony Guimaraes, was featured on GenomeWeb for his work alongside a team of colleagues from the Federal University of Minas Gerai in Brazil who developed an open-source software tool to enable researchers and clinicians to home in on disease-causing variants for Mendelian disorders in genomic data.
Their tool, called Mendel,MD, analyses and annotates exome or genome data, compares it against a number of databases, and filters it to identify a list of candidate disease-causing mutations.
GMI co-founder, Dr. Sean Ennis, was hosted by the Ireland Strategic Investment Fund (ISIF) to join the discussion with other ISIF investment companies at the “Investing in Ireland – 2020 and Beyond” conference held today at the Convention Centre Dublin.
Dr. Kari Stefansson and Dr. Paul Saunders Appointed to the Board
Irish life sciences company Genomics Medicine Ireland Ltd., has today announced the appointment of Dr. Kari Stefansson and Dr. Paul Saunders to its Board of Directors. The appointment will increase the size of the Genomics Medicine Ireland Board of Directors to six members. Read More
Genomics Medicine Ireland was featured in Silicon Republic’s 25 Interesting European AI start-ups to watch in 2017 as one of the Irish companies carrying the torch for this technology revolution.
Genomic information from thousands of people in Ireland may unearth new clues in the hunt for markers of disease and new medicines to treat them.
Read the recent interview with GMI co-founder, Dr. Sean Ennis, on AbbVie’s website.